T-477, a novel Ca 2+ - and Na + channel blocker, prevents veratridine-induced neuronal injury

By Okuyama K.   Kiuchi S.   Okamoto M.   Narita H.   Kudo Y.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Chronic inhibition of intracellular Ca 2+ release or protein kinase C activation significantly reduces the development of morphine dependence

By Fundytus M.E.   Coderre T.J.  

European Journal of Pharmacology, Vol. 300, Iss. 3, 1996-04 ,pp. : 173-181

Elsevier

Access to resources Recommend Favorite

Antisympathetic and hemodynamic property of a dual L/N-type Ca 2+ channel blocker cilnidipine in rats

By Takahara A.   Koganei H.   Takeda T.   Iwata S.  

European Journal of Pharmacology, Vol. 434, Iss. 1, 2002-01 ,pp. : 43-47

Elsevier

Access to resources Recommend Favorite

-Agatoxin IVA-sensitive Ca 2+ channel blocker, -eudesmol, protects against brain injury after focal ischemia in rats

By Asakura K.   Matsuo Y.   Oshima T.   Kihara T.   Minagawa K.   Araki Y.   Kagawa K.   Kanemasa T.   Ninomiya M.  

European Journal of Pharmacology, Vol. 394, Iss. 1, 2000-04 ,pp. : 57-65

Elsevier

Access to resources Recommend Favorite

Effects of semotiadil, a novel Ca 2+ channel antagonist, on the electrical activity of Langendorff-perfused guinea pig hearts in comparison with diltiazem, amlodipine and nifedipine

By Stark G.   Kasper K.   Stark U.   Miyawaki N.   Decrinis M.   Tritthart H.A.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 71-78

Elsevier

Access to resources Recommend Favorite